| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Mayleben Timothy M is a President &CEO at Esperion Therapeutics, Inc.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $388K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2016 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 3,600 | $15.88 | $57,168.00 | +11.6% | |
| Jan 15, 2016 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 7,200 | $14.08 | $101,376.00 | +30.2% |